Use this link to cite:
https://hdl.handle.net/2183/48294 Decadentate Acyclic Chelators for Lanthanum Radiopharmaceuticals
Loading...
Identifiers
Publication date
Authors
Argibay-Otero, Saray
Tircsó, Gyula
Wuest, Frank
Advisors
Other responsabilities
Journal Title
Bibliographic citation
J. Med. Chem. 2025, 68, 16, 17823–17839 https://doi.org/10.1021/acs.jmedchem.5c01558
Type of academic work
Academic degree
Abstract
[Abstract]Two decadentate acyclic chelators bearing four picolinic acid groups appended on either an ethylenediamine (H4TPAEN) or a trans-1,2-cyclohexyldiamine (H4TPADAC) unit were explored as candidates for lanthanum-based radiopharmaceutical development. The two chelators form ten-coordinated complexes with La3+ in the solid state, as evidenced by the corresponding X-ray structures and solution NMR studies. The La3+ complexes of TPAEN4– and TPADAC4– are characterized by high thermodynamic stability constants of log KLaL = 19.16(8) and 19.55(1), respectively. Kinetics studies indicate that the complexes dissociate following the acid-catalyzed and Cu2+-assisted pathways. Quantitative radiolabeling of both chelators with [135La]La3+ was achieved at pH ∼ 4–5 using straightforward protocols and low concentrations of the chelator (3 μM). Both in vitro and in vivo studies indicate that the [135La]La3+ complex of TPAEN4– is significantly more stable than the TPADAC4– analogue, with the former remaining intact and stable even after 60 min in vivo when injected to healthy mice
Description
Editor version
Rights
© 2025 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0
Attribution 4.0 International
Attribution 4.0 International








